SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001178913-19-002091
Filing Date
2019-08-07
Accepted
2019-08-07 16:19:37
Documents
60
Period of Report
2019-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q zk1923343.htm 10-Q 1125719
2 EXHIBIT 31.1 exhibit_31-1.htm EX-31.1 13665
3 EXHIBIT 31.2 exhibit_31-2.htm EX-31.2 13523
4 EXHIBIT 32.1 exhibit_32-1.htm EX-32.1 4704
5 EXHIBIT 32.2 exhibit_32-2.htm EX-32.2 4547
  Complete submission text file 0001178913-19-002091.txt   4213501

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT fomx-20190630.xml EX-101.INS 797760
7 XBRL TAXONOMY EXTENSION SCHEMA fomx-20190630.xsd EX-101.SCH 39207
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE fomx-20190630_cal.xml EX-101.CAL 54125
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE fomx-20190630_def.xml EX-101.DEF 128913
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE fomx-20190630_lab.xml EX-101.LAB 304303
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE fomx-20190630_pre.xml EX-101.PRE 218611
Mailing Address 2 HOLZMAN ST. WEIZMANN SCIENCE PARK REHOVOT L3 76704
Business Address 2 HOLZMAN ST. WEIZMANN SCIENCE PARK REHOVOT L3 76704 97289316233
Foamix Pharmaceuticals Ltd. (Filer) CIK: 0001606645 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36621 | Film No.: 191005764
SIC: 2833 Medicinal Chemicals & Botanical Products